Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
STWB Inc
Original Assignee
Sterling Drug Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Drug IncfiledCriticalSterling Drug Inc
Application grantedgrantedCritical
Publication of CA1260941ApublicationCriticalpatent/CA1260941A/fr
N-alkylamides of D(+)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same
N-alkylamides of D,L and L(-)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same
N-((Alkyl ou arylméthyl)-1 1H-pyridylidène-4) alcaneamines antimicrobiennes, leurs sels d'addition, leur procédé de préparation, leurs méthodes d'utilisation et leurs compositions
SEMISYNTHETIC β-LACTAM ANTIBIOTICS II. EFFECT ON ANTIBACTERIAL ACTIVITY OF UREIDO NSUBSTITUENTS IN THE 6-[(R)-2-[3-(3, 4-DIHYDROXYBENZOYL)-1-UREIDO]-2-PHENYLACETAMIDO] PENICILLANIC ACIDS
N-alkylamides of d(+)-carnitine having antibacterial activity, process for their preparation and pharmaceutical and cosmetic compositions containing same